Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,667 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of olfactory bulb pathology on olfactory function in normal aging.
Tremblay C, Serrano GE, Intorcia AJ, Sue LI, Wilson JR, Adler CH, Shill HA, Driver-Dunckley E, Mehta SH, Beach TG. Tremblay C, et al. Among authors: wilson jr. Brain Pathol. 2022 Sep;32(5):e13075. doi: 10.1111/bpa.13075. Epub 2022 Apr 29. Brain Pathol. 2022. PMID: 35485279 Free PMC article.
Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition.
Filon JR, Intorcia AJ, Sue LI, Vazquez Arreola E, Wilson J, Davis KJ, Sabbagh MN, Belden CM, Caselli RJ, Adler CH, Woodruff BK, Rapscak SZ, Ahern GL, Burke AD, Jacobson S, Shill HA, Driver-Dunckley E, Chen K, Reiman EM, Beach TG, Serrano GE. Filon JR, et al. Among authors: wilson j. J Neuropathol Exp Neurol. 2016 Aug;75(8):748-754. doi: 10.1093/jnen/nlw047. Epub 2016 Jun 12. J Neuropathol Exp Neurol. 2016. PMID: 27297671 Free PMC article.
Poor Safety and Tolerability Hamper Reaching a Potentially Therapeutic Dose in the Use of Thalidomide for Alzheimer's Disease: Results from a Double-Blind, Placebo-Controlled Trial.
Decourt B, Drumm-Gurnee D, Wilson J, Jacobson S, Belden C, Sirrel S, Ahmadi M, Shill H, Powell J, Walker A, Gonzales A, Macias M, Sabbagh MN. Decourt B, et al. Curr Alzheimer Res. 2017;14(4):403-411. doi: 10.2174/1567205014666170117141330. Curr Alzheimer Res. 2017. PMID: 28124585 Free PMC article. Clinical Trial.
MCLENA-1: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Lenalidomide in Patients with Mild Cognitive Impairment Due to Alzheimer's Disease.
Decourt B, Wilson J, Ritter A, Dardis C, DiFilippo FP, Zhuang X, Cordes D, Lee G, Fulkerson ND, St Rose T, Hartley K, Sabbagh MN. Decourt B, et al. Open Access J Clin Trials. 2020;12:1-13. doi: 10.2147/oajct.s221914. Epub 2020 Jan 7. Open Access J Clin Trials. 2020. PMID: 32123490 Free PMC article.
1,667 results